List of Excipients in Branded Drug IBUPROFEN

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Lupin Pharmaceuticals Inc	IBUPROFEN AND FAMOTIDINE	ibuprofen and famotidine	70748-312	CELLULOSE, MICROCRYSTALLINE
Lupin Pharmaceuticals Inc	IBUPROFEN AND FAMOTIDINE	ibuprofen and famotidine	70748-312	CROSCARMELLOSE SODIUM
Lupin Pharmaceuticals Inc	IBUPROFEN AND FAMOTIDINE	ibuprofen and famotidine	70748-312	FD&C BLUE NO. 1
Lupin Pharmaceuticals Inc	IBUPROFEN AND FAMOTIDINE	ibuprofen and famotidine	70748-312	FD&C BLUE NO. 2--ALUMINUM LAKE

Generic Drugs Containing IBUPROFEN

Company	Ingredient	NDC	Excipient
Pharmaceutical Associates Inc	ibuprofen	0121-0918	ACESULFAME POTASSIUM
Pharmaceutical Associates Inc	ibuprofen	0121-0918	ANHYDROUS CITRIC ACID
Pharmaceutical Associates Inc	ibuprofen	0121-0918	GLYCERIN
Pharmaceutical Associates Inc	ibuprofen	0121-0918	POLYSORBATE 80

What are the Most Frequently-Used Excipients in IBUPROFEN?

# Of NDCs	Excipient
6	1,4-SORBITAN
50	ACESULFAME POTASSIUM
11	ALUMINUM OXIDE
31	AMMONIA

Excipient Strategy and Commercial Opportunities for Ibuprofen

Last updated: February 28, 2026

What is the current excipient profile for ibuprofen formulations?

Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is available in various formulations, including tablets, capsules, liquids, and topical preparations. Common excipients include:

• Binders: Starch, povidone
• Fillers: Microcrystalline cellulose, lactose
• Disintegrants: Sodium starch glycolate, croscarmellose sodium
• Lubricants: Magnesium stearate, stearic acid
• Coatings: Hypromellose (for film coatings)

The choice of excipients varies by formulation type, desired release profile, and manufacturing process.

How do excipient choices influence ibuprofen’s efficacy and stability?

Excipient selection impacts drug bioavailability, stability, and patient tolerability. For example:

• Bioavailability: Using disintegrants like croscarmellose enhances dissolution speed.
• Stability: Antioxidants like sodium bisulfite prevent oxidation of sensitive compounds.
• Tolerability: Coatings with hypromellose mask unpleasant taste and reduce gastrointestinal irritation.

Optimizing excipients can extend shelf life and improve pharmacokinetic profiles, enabling differentiated product offerings.

What are current trends in excipient innovation relevant to ibuprofen?

Emerging trends include:

• Solubility-enhancing excipients: Use of cyclodextrins to improve bioavailability of poorly soluble ibuprofen.
• Controlled-release systems: Employing polymer matrices to prolong drug release, reducing dosing frequency.
• Pediatric and adult specialized excipients: Flavored, easy-to-swallow formulations for children; reduced excipient allergens for sensitive populations.

Novel excipients like superdisintegrants or lipid-based carriers can correct for formulation challenges.

What commercial opportunities exist with excipient strategies for ibuprofen?

Opportunities lie in:

• Formulation differentiation: Developing liquid gels, chronotherapeutic tablets, or chewables with optimized excipients enhances competitive positioning.
• Patent extensions: Novel excipient combinations or delivery systems allow for patent filings, extending market exclusivity.
• Enhanced bioavailability: Excipient innovations that improve absorption can justify premium pricing.
• Targeted delivery: Site-specific formulations reduce systemic side effects and open channels into niche markets such as sensitive populations or chronic conditions.

The global NSAID market surpasses USD 15 billion, with ibuprofen commanding substantial share. Excipients serve as tools to create products that meet unmet needs or regulatory standards, further expanding market potential.

What regulatory considerations influence excipient use for ibuprofen?

Regulatory agencies, including the FDA and EMA, emphasize excipient safety, especially for products intended for children or chronic use. Key points include:

• GRAS status: Excipients must be Generally Recognized as Safe.
• Transparency: Clear listing of excipient components.
• Novel excipients: Require extensive safety data and justification.
• Manufacturing controls: Ensure excipient quality, stability, and impurity limits.

Regulatory compliance influences formulation design and can impact time-to-market and costs.

How does excipient supply chain impact commercial strategy?

Excipients constitute critical raw materials with supply chains that can affect production costs and timelines. Providers of high-quality, reliable excipients, especially for advanced formulations, have a competitive edge. Supply chain risks include:

• Raw material shortages
• Quality variability
• Regulatory constraints

Long-term contracts and diversified sourcing mitigate these risks, enabling consistent product supply.

Closing summary

Innovation in excipient use for ibuprofen involves balancing formulation performance with regulatory compliance and supply chain stability. Opportunities exist in developing formulations with improved bioavailability, targeted delivery, and patient-specific characteristics. Companies that pursue novel excipients or delivery systems can differentiate products and extend market longevity.

Key Takeaways

• Excipient choice impacts bioavailability, stability, and patient tolerability.
• Trends favor solubility enhancers, controlled-release systems, and pediatric-friendly excipients.
• Commercial opportunities include product differentiation, patenting, and premium pricing.
• Regulatory requirements demand safety validation, influencing formulation strategies.
• Supply chain robustness for excipients underpins consistent production and market strategy.

FAQs

1. What are the most common excipients used in ibuprofen tablets?
Microcrystalline cellulose, starch, sodium starch glycolate, magnesium stearate, and hypromellose.

2. Can novel excipients improve ibuprofen bioavailability?
Yes. Cyclodextrins and lipid-based carriers can enhance solubility and absorption.

3. What excipient innovations can extend ibuprofen patent life?
Controlled-release mechanisms and targeted delivery systems utilizing novel excipients.

4. How do regulatory agencies influence excipient selection?
They require safety data, transparency, and compliance with specific standards, especially for vulnerable populations.

5. What supply chain factors are critical for excipients in ibuprofen manufacturing?
Raw material availability, quality consistency, and regulatory compliance are essential.

---

References

1. Aulton, M. E., & Taylor, K. M. G. (2013). Pharmaceutics: The Science of Dosage Form Design. Churchill Livingstone.
2. US Food and Drug Administration. (2022). Guidance for Industry: Excipients in FDA-Approved Drug Products [Online resource].
3. European Medicines Agency. (2021). Guideline on Excipients in the Labeling and Planting of Medicinal Products.
4. Kumar, S., et al. (2020). Excipient innovations for enhanced drug delivery. Journal of Pharmaceutical Sciences, 109(4), 1264–1272.